Łukasz Szukalski

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial

Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak et al. · The Lancet Oncology · 2023 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

Marta Sobas, Jean‐Jacques Kiladjian, Yan Beauverd et al. · Blood Advances · 2022 · 43 citations · Full text

Medicine, Hematology, Pediatrics +15

Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study

Elżbieta Kalicińska, Monika Biernat, Justyna Rybka et al. · Journal of Clinical Medicine · 2021 · 34 citations · Full text

Medicine, Hematology, Oncology +17

Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma

Tadeusz Kubicki, Dominik Dytfeld, David R. Barnidge et al. · Blood · 2024 · 31 citations · Full text

Life Sciences, Biochemistry, Hematology +17

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

Sarah Goldman‐Mazur, Artur Jurczyszyn, Jorge J. Castillo et al. · American Journal of Hematology · 2020 · 30 citations · Full text

Medicine, Hematology, Oncology +16